Literature DB >> 19187764

Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.

Bin Zheng1, Joseph H Jeong, John M Asara, Yuan-Ying Yuan, Scott R Granter, Lynda Chin, Lewis C Cantley.   

Abstract

The LKB1-AMPK signaling pathway serves as a critical cellular sensor coupling energy homeostasis to cell growth, proliferation, and survival. However, how tumor cells suppress this signaling pathway to gain growth advantage under conditions of energy stress is largely unknown. Here, we show that AMPK activation is suppressed in melanoma cells with the B-RAF V600E mutation and that downregulation of B-RAF signaling activates AMPK. We find that in these cells LKB1 is phosphorylated by ERK and Rsk, two kinases downstream of B-RAF, and that this phosphorylation compromises the ability of LKB1 to bind and activate AMPK. Furthermore, expression of a phosphorylation-deficient mutant of LKB1 allows activation of AMPK and inhibits melanoma cell proliferation and anchorage-independent cell growth. Our findings provide a molecular linkage between the LKB1-AMPK and the RAF-MEK-ERK pathways and suggest that suppression of LKB1 function by B-RAF V600E plays an important role in B-RAF V600E-driven tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187764      PMCID: PMC2715556          DOI: 10.1016/j.molcel.2008.12.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  62 in total

Review 1.  The RAF proteins take centre stage.

Authors:  Claudia Wellbrock; Maria Karasarides; Richard Marais
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 2.  Guilty as charged: B-RAF is a human oncogene.

Authors:  Mathew J Garnett; Richard Marais
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

3.  Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas.

Authors:  A Rowan; V Bataille; R MacKie; E Healy; D Bicknell; W Bodmer; I Tomlinson
Journal:  J Invest Dermatol       Date:  1999-04       Impact factor: 8.551

4.  Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.

Authors:  P Guldberg; P thor Straten; V Ahrenkiel; T Seremet; A F Kirkin; J Zeuthen
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

5.  Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.

Authors:  M Tiainen; A Ylikorkala; T P Mäkelä
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Analysis of the LKB1-STRAD-MO25 complex.

Authors:  Jérôme Boudeau; John W Scott; Nicoletta Resta; Maria Deak; Agnieszka Kieloch; David Komander; D Grahame Hardie; Alan R Prescott; Daan M F van Aalten; Dario R Alessi
Journal:  J Cell Sci       Date:  2004-11-23       Impact factor: 5.285

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.

Authors:  Xiaoqin Xiang; Asish K Saha; Rong Wen; Neil B Ruderman; Zhijun Luo
Journal:  Biochem Biophys Res Commun       Date:  2004-08-13       Impact factor: 3.575

9.  De novo germline mutation in the serine-threonine kinase STK11/LKB1 gene associated with Peutz-Jeghers syndrome.

Authors:  I Hernan; I Roig; B Martin; M J Gamundi; M Martinez-Gimeno; M Carballo
Journal:  Clin Genet       Date:  2004-07       Impact factor: 4.438

10.  Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.

Authors:  Simon A Hawley; Jérôme Boudeau; Jennifer L Reid; Kirsty J Mustard; Lina Udd; Tomi P Mäkelä; Dario R Alessi; D Grahame Hardie
Journal:  J Biol       Date:  2003-09-24
View more
  167 in total

Review 1.  Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.

Authors:  Inna V Fedorenko; Kim H T Paraiso; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2011-05-25       Impact factor: 5.858

2.  Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Authors:  Vanessa Fritz; Zohra Benfodda; Geneviève Rodier; Corinne Henriquet; François Iborra; Christophe Avancès; Yves Allory; Alexandre de la Taille; Stéphane Culine; Hubert Blancou; Jean Paul Cristol; Françoise Michel; Claude Sardet; Lluis Fajas
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

3.  Liver kinase B1 (LKB1) in the pathogenesis of UVB-induced murine basal cell carcinoma.

Authors:  Yevgeniya A Byekova; Jennifer L Herrmann; Jianmin Xu; Craig A Elmets; Mohammad Athar
Journal:  Arch Biochem Biophys       Date:  2011-01-25       Impact factor: 4.013

Review 4.  AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.

Authors:  D Grahame Hardie
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

5.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

6.  Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.

Authors:  Nuria Martínez-López; Juan L García-Rodríguez; Marta Varela-Rey; Virginia Gutiérrez; David Fernández-Ramos; Naiara Beraza; Ana M Aransay; Karin Schlangen; Juan Jose Lozano; Patricia Aspichueta; Zigmund Luka; Conrad Wagner; Matthias Evert; Diego F Calvisi; Shelly C Lu; José M Mato; María L Martínez-Chantar
Journal:  Gastroenterology       Date:  2012-06-08       Impact factor: 22.682

Review 7.  Precision Medicine and PET/Computed Tomography in Melanoma.

Authors:  Esther Mena; Yasemin Sanli; Charles Marcus; Rathan M Subramaniam
Journal:  PET Clin       Date:  2017-07-14

8.  LKB1 inhibition of NF-κB in B cells prevents T follicular helper cell differentiation and germinal center formation.

Authors:  Nicole C Walsh; Lynnea R Waters; Jessica A Fowler; Mark Lin; Cameron R Cunningham; David G Brooks; Jerold E Rehg; Herbert C Morse; Michael A Teitell
Journal:  EMBO Rep       Date:  2015-04-26       Impact factor: 8.807

Review 9.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

10.  Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.

Authors:  Che-Hung Shen; Ping Yuan; Rolando Perez-Lorenzo; Yaqing Zhang; Sze Xian Lee; Yang Ou; John M Asara; Lewis C Cantley; Bin Zheng
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.